4 Merger and Acquisitions Stock Stories Making Midweek Headlines

Yahoo! Inc. (NASDAQ:YHOO): Current price $29.66

On Wednesday, Yahoo! announced the purchase of the advanced mobile ad tech startup Admovate. The firm has created sophisticated technology that helps marketers reach their desired audience at the right time and place, according to the buyer’s website. The firm added, “This is especially important for mobile ad experiences that engage consumers on smaller screens. This acquisition is part of our efforts to invest further in our ad tech platforms — Apt, Genome, and Right Media — and make buying easier for advertisers and agencies. Admovate’s personalization technology accelerates our capabilities in mobile advertising, and we gain an exceptionally talented technical team. Admovate’s engineers will join our Yahoo! display advertising team in Sunnyvale.”

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

YHOO

PepsiCo Inc. (NYSE:PEP): Current price $85.31

Three knowledgeable sources believe that a timeframe agreed upon by PepsiCo Inc. and Trian Fund Management’s Nelson Peltz, which would privately address the latter’s suggestions for enhancing shareholder returns, might be coming to an end. Peltz revealed a position in PepsiCo in April, when the soft drink and snack maker said it held meetings with Trian “to discuss and consider their ideas.” PepsiCo did not report what those ideas were, although a concurrent acquisition of Mondelez International Inc. shares drove speculation that Peltz would insist upon a merger.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

PEP

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI): Current price $8.76

On Wednesday, Spectrum announced that it will acquire bio-pharmaceutical firm Talon Therapeutics Inc. by means of a wholly-owned subsidiary, and that it expects to finalize the purchase within a day. At the close, Spectrum will pay Talon stockholders a total upfront cash consideration of about $11.3 million, and will issue 3 million shares of its common stock in return for the cancellation of all outstanding indebtedness under Talons credit facility. Spectrum is a biotech company that has fully integrated commercial and drug development operations, with a primary concentration in hematology and oncology.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

SPPI

RTI Biologics Inc. (NASDAQ: RTIX): Current price $4.25

The supplier of orthopedic and other biologic implants announced Wednesday that it has concluded the purchase of Pioneer Surgical Technology. RTI previously reported its plans to buy all outstanding stock in Pioneer for $130 million in cash on June 12.

Are these stocks a buy or sell? Let us help you decide. RTIX

Don’t Miss: Is the Housing Recovery Theme Getting Demolished?